Rallis India Q1 FY27: Revenue up 7% to ₹1022 Cr, PAT surges 31% to ₹125 Cr
Rallis India reported Q1 FY27 results with revenue growing 7% YoY to ₹1022 crore and PAT surging 31% to ₹125 crore. The company launched new products in Crop Care and Seeds segments, aiming to strengthen its portfolio and drive profitability.
The results show a healthy growth in key financial metrics and strategic product introductions, which are likely to positively influence investor confidence and market position.
The company reported positive year-on-year growth in revenue and a significant increase in Profit After Tax, along with new product launches, indicating a strong business performance.
Rallis India Limited announced its un-audited financial results for the quarter ended June 30, 2026, reporting a 7% year-on-year revenue growth to ₹1022 crore from ₹957 crore in the corresponding quarter of the previous year.
The company's Profit After Tax (PAT) saw a significant increase of 31%, reaching ₹125 crore compared to ₹95 crore in the prior year's quarter.
In terms of business performance, the Crop Care segment reported a 7% YoY revenue growth to ₹697 crore, driven by a 19% increase in the B2C segment, despite a 19% decline in the B2B segment. Three new products were launched: Balwan (Herbicide), Prodim Ultra (Herbicide), and Kengen (Insecticide).
The Soil & Plant Health (SPH) segment achieved a 10% YoY growth, supported by portfolio management and pricing actions. The commercial launch of Aquafert Ginger and Turmeric contributed to this growth.
The Seeds business recorded a 6% YoY revenue increase to ₹325 crore, attributed to strategic product placements and pre-season initiatives. Nine new products were launched across Cotton, Paddy, and Millet crops, including two new Cotton hybrids and a Herbicide Tolerant Direct Seed Rice product.
Dr. Gyanendra Shukla, Managing Director & CEO, Rallis India Limited, commented on the performance, stating, "During the quarter, we continued to strengthen our product portfolio through new product introductions across businesses while driving improved profitability through disciplined pricing actions and cost optimization initiatives. We remain committed to delivering differentiated solutions that address the evolving needs of Indian agriculture through continued investments in innovation, customer-centricity and operational excellence."
What to do with a filing like this
Rallis India Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Rallis India Limited. Read the original for the full detail.